AJCN North Carolina Research Campus
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Blanchard, J.
Right arrow Articles by Rowland, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Blanchard, J.
Right arrow Articles by Rowland, M.
Agricola
Right arrow Articles by Blanchard, J.
Right arrow Articles by Rowland, M.

American Journal of Clinical Nutrition, Vol 66, 1165-1171, Copyright © 1997 by The American Society for Clinical Nutrition, Inc

REVIEW ARTICLES

Pharmacokinetic perspectives on megadoses of ascorbic acid

J Blanchard, TN Tozer and M Rowland
Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, USA. BLANCHRD@tonic.pharm.arizona.edu

Ascorbic acid (vitamin C) is commonly used as a dietary supplement, often in megadoses. However, as the daily oral dose is increased, the concentration of ascorbic acid in the plasma and other body fluids does not increase proportionally, but instead tends to approach an upper limit. For example, when the daily dose is increased from 200 to 2500 mg (from 1.1 to 14.2 mmol) the mean steady state plasma concentration increases only from approximately 12 to 15 mg/L (from 68.1 to 85.2 mumol/L). Published data were reanalyzed with an integrated modeling approach to shed new quantitative light on this phenomenon. This analysis is based on the renal clearance of ascorbic acid, which rises sharply with increasing plasma concentrations as a result of saturable tubular reabsorption. The analysis indicates that both saturable gastrointestinal absorption and nonlinear renal clearance act additively to produce the ceiling effect in plasma concentrations. As a consequence of this ceiling effect, there is no pharmacokinetic justification for the use of megadoses of ascorbic acid.


This article has been cited by other articles:


Home page
 The Annals of PharmacotherapyHome page
J. Duconge, J. R Miranda-Massari, M. J Gonzalez, P. R Taylor, H. D Riordan, N. H Riordan, J. J Casciari, and K. Alliston
Vitamin C Pharmacokinetics after Continuous Infusion in a Patient with Prostate Cancer
Ann. Pharmacother., June 1, 2007; 41(6): 1082 - 1083.
[Full Text] [PDF]

Home page
 Integr Cancer TherHome page
M. J. Gonzalez, J. R. Miranda-Massari, E. M. Mora, A. Guzman, N. H. Riordan, H. D. Riordan, J. J. Casciari, J. A. Jackson, and A. Roman-Franco
Orthomolecular Oncology Review: Ascorbic Acid and Cancer 25 Years Later
Integr Cancer Ther, March 1, 2005; 4(1): 32 - 44.
[Abstract] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
E. N. Taylor, M. J. Stampfer, and G. C. Curhan
Dietary Factors and the Risk of Incident Kidney Stones in Men: New Insights after 14 Years of Follow-up
J. Am. Soc. Nephrol., December 1, 2004; 15(12): 3225 - 3232.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
K. Spargias, E. Alexopoulos, S. Kyrzopoulos, P. Iacovis, D. C. Greenwood, A. Manginas, V. Voudris, G. Pavlides, C. E. Buller, D. Kremastinos, et al.
Ascorbic Acid Prevents Contrast-Mediated Nephropathy in Patients With Renal Dysfunction Undergoing Coronary Angiography or Intervention
Circulation, November 2, 2004; 110(18): 2837 - 2842.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Coll. Nutr.Home page
M. K. Kim, S. Sasazuki, S. Sasaki, S. Okubo, M. Hayashi, and S. Tsugane
Effect of Five-Year Supplementation of Vitamin C on Serum Vitamin C Concentration and Consumption of Vegetables and Fruits in Middle-Aged Japanese: A Randomized Controlled Trial
J. Am. Coll. Nutr., June 1, 2003; 22(3): 208 - 216.
[Abstract] [Full Text]

Home page
 CirculationHome page
J. Pleiner, F. Mittermayer, G. Schaller, R. J. MacAllister, and M. Wolzt
High Doses of Vitamin C Reverse Escherichia coli Endotoxin-Induced Hyporeactivity to Acetylcholine in the Human Forearm
Circulation, September 17, 2002; 106(12): 1460 - 1464.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 by The American Society for Nutrition